594 related articles for article (PubMed ID: 26852737)
1. COPD and the microbiome.
Mammen MJ; Sethi S
Respirology; 2016 May; 21(4):590-9. PubMed ID: 26852737
[TBL] [Abstract][Full Text] [Related]
2. The lung microbiome dynamics between stability and exacerbation in chronic obstructive pulmonary disease (COPD): Current perspectives.
Dima E; Kyriakoudi A; Kaponi M; Vasileiadis I; Stamou P; Koutsoukou A; Koulouris NG; Rovina N
Respir Med; 2019 Oct; 157():1-6. PubMed ID: 31450162
[TBL] [Abstract][Full Text] [Related]
3. Bacterial microbiome of lungs in COPD.
Sze MA; Hogg JC; Sin DD
Int J Chron Obstruct Pulmon Dis; 2014; 9():229-38. PubMed ID: 24591822
[TBL] [Abstract][Full Text] [Related]
4. The lung microbiome and exacerbations of COPD.
Dy R; Sethi S
Curr Opin Pulm Med; 2016 May; 22(3):196-202. PubMed ID: 26964078
[TBL] [Abstract][Full Text] [Related]
5. Dynamic changes of gut and lung microorganisms during chronic obstructive pulmonary disease exacerbations.
Sun Z; Zhu QL; Shen Y; Yan T; Zhou X
Kaohsiung J Med Sci; 2020 Feb; 36(2):107-113. PubMed ID: 31782610
[TBL] [Abstract][Full Text] [Related]
6. The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations.
Huang YJ; Boushey HA
Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2(Suppl 2):S176-80. PubMed ID: 26595736
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
Mayhew D; Devos N; Lambert C; Brown JR; Clarke SC; Kim VL; Magid-Slav M; Miller BE; Ostridge KK; Patel R; Sathe G; Simola DF; Staples KJ; Sung R; Tal-Singer R; Tuck AC; Van Horn S; Weynants V; Williams NP; Devaster JM; Wilkinson TMA;
Thorax; 2018 May; 73(5):422-430. PubMed ID: 29386298
[TBL] [Abstract][Full Text] [Related]
8. The lung microbiome in moderate and severe chronic obstructive pulmonary disease.
Pragman AA; Kim HB; Reilly CS; Wendt C; Isaacson RE
PLoS One; 2012; 7(10):e47305. PubMed ID: 23071781
[TBL] [Abstract][Full Text] [Related]
9. Chronic obstructive pulmonary disease and infection. Disruption of the microbiome?
Sethi S
Ann Am Thorac Soc; 2014 Jan; 11 Suppl 1():S43-7. PubMed ID: 24437405
[TBL] [Abstract][Full Text] [Related]
10. Variations in fecal microbial profiles of acute exacerbations and stable chronic obstructive pulmonary disease.
Wu Y; Luo Z; Liu C
Life Sci; 2021 Jan; 265():118738. PubMed ID: 33181175
[TBL] [Abstract][Full Text] [Related]
11. Role of the Lung Microbiome in the Pathogenesis of Chronic Obstructive Pulmonary Disease.
Wang L; Hao K; Yang T; Wang C
Chin Med J (Engl); 2017 Sep; 130(17):2107-2111. PubMed ID: 28741603
[TBL] [Abstract][Full Text] [Related]
12. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state.
Yang CY; Li SW; Chin CY; Hsu CW; Lee CC; Yeh YM; Wu KA
J Transl Med; 2021 Mar; 19(1):121. PubMed ID: 33757530
[TBL] [Abstract][Full Text] [Related]
13. Sputum Microbiome Dynamics in Chronic Obstructive Pulmonary Disease Patients during an Exacerbation Event and Post-Stabilization.
López Caro JC; Santibáñez M; García Rivero JL; Villanueva M; Sainz J; González Astorqui P; Hierro M; Rodríguez Porres M; Paras Bravo P; Mira A; Rodriguez JC; Galiana A;
Respiration; 2019; 98(5):447-454. PubMed ID: 31437842
[TBL] [Abstract][Full Text] [Related]
14. Microbial burden and viral exacerbations in a longitudinal multicenter COPD cohort.
Bouquet J; Tabor DE; Silver JS; Nair V; Tovchigrechko A; Griffin MP; Esser MT; Sellman BR; Jin H
Respir Res; 2020 Mar; 21(1):77. PubMed ID: 32228581
[TBL] [Abstract][Full Text] [Related]
15. Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis.
Ramsheh MY; Haldar K; Esteve-Codina A; Purser LF; Richardson M; Müller-Quernheim J; Greulich T; Nowinski A; Barta I; Stendardo M; Boschetto P; Korzybski D; Prasse A; Parr DG; Hohlfeld JM; Döme B; Welte T; Heath S; Gut I; Morrissey JA; Ziegler-Heitbrock L; Barer MR; Singh D; Brightling CE
Lancet Microbe; 2021 Jul; 2(7):e300-e310. PubMed ID: 35544166
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the lung microbiome in the "healthy" smoker and in COPD.
Erb-Downward JR; Thompson DL; Han MK; Freeman CM; McCloskey L; Schmidt LA; Young VB; Toews GB; Curtis JL; Sundaram B; Martinez FJ; Huffnagle GB
PLoS One; 2011 Feb; 6(2):e16384. PubMed ID: 21364979
[TBL] [Abstract][Full Text] [Related]
17. Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort.
Opron K; Begley LA; Erb-Downward JR; Freeman C; Madapoosi S; Alexis NE; Barjaktarevic I; Graham Barr R; Bleecker ER; Bowler RP; Christenson SA; Comellas AP; Cooper CB; Couper DJ; Doerschuk CM; Dransfield MT; Han MK; Hansel NN; Hastie AT; Hoffman EA; Kaner RJ; Krishnan J; O'Neal WK; Ortega VE; Paine R; Peters SP; Michael Wells J; Woodruff PG; Martinez FJ; Curtis JL; Huffnagle GB; Huang YJ
NPJ Biofilms Microbiomes; 2021 Feb; 7(1):14. PubMed ID: 33547327
[TBL] [Abstract][Full Text] [Related]
18. The lung tissue microbiome in chronic obstructive pulmonary disease.
Sze MA; Dimitriu PA; Hayashi S; Elliott WM; McDonough JE; Gosselink JV; Cooper J; Sin DD; Mohn WW; Hogg JC
Am J Respir Crit Care Med; 2012 May; 185(10):1073-80. PubMed ID: 22427533
[TBL] [Abstract][Full Text] [Related]
19. The microbiome of the lung and its extracellular vesicles in nonsmokers, healthy smokers and COPD patients.
Kim HJ; Kim YS; Kim KH; Choi JP; Kim YK; Yun S; Sharma L; Dela Cruz CS; Lee JS; Oh YM; Lee SD; Lee SW
Exp Mol Med; 2017 Apr; 49(4):e316. PubMed ID: 28408748
[TBL] [Abstract][Full Text] [Related]
20. Lung microbiome dynamics in COPD exacerbations.
Wang Z; Bafadhel M; Haldar K; Spivak A; Mayhew D; Miller BE; Tal-Singer R; Johnston SL; Ramsheh MY; Barer MR; Brightling CE; Brown JR
Eur Respir J; 2016 Apr; 47(4):1082-92. PubMed ID: 26917613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
